Entity/Public Space Stock Epinephrine

Stock epinephrine is rapidly moving beyond the school walls and out to public venues – from theme parks, restaurants and sports arenas to daycare centers and more.

Thirty-two states have now passed what are called “entity laws” (as of October 30, 2018), legislation that permits venues to maintain an epinephrine auto-injector, with the intention of reducing the time it takes to get lifesaving epinephrine to a person having a sudden anaphylactic reaction.

States colored red are without entity legislation.

Click on the state listings below to read the legislation.

 

 Green states:  Red states:
Alaska Connecticut
Alabama Delaware
Arkansas Hawaii
Arizona Kansas
California Louisiana
Colorado Maryland
District of Columbia  Massachusetts
Florida Mississippi
Georgia  Montana
Idaho Nebraska
Illinois New Mexico
Indiana North Dakota
Iowa South Dakota
Kentucky Texas
Michigan Vermont
Minnesota  Virginia
Missouri Wyoming
Maine
Nevada
New Hampshire
New Jersey
New York
North Carolina
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
Tennessee
Utah
Washington
West Virginia
Wisconsin

For questions and to get involved in Entity Legislation in your state, contact Charmayne Anderson at canderson@allergyasthmanetwork.org or 800.878.4403.